All In MedTech

FDA Clearance Tracker · P810006

COLLASTAT

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Dec 10, 1981 (this decision)Source: openFDAMethods & limitations

PMA

Decided

Dec 10, 1981

Approved

Time to decision

283 days

Received Mar 2, 1981. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P810006
Device name
COLLASTAT
Applicant location
Planisboro, NJ
Received
Mar 2, 1981
Decided
Dec 10, 1981
Decision
Approved
Supplements
107 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III
Regulation
21 CFR 878.4490

Every decision under product code LMF

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code LMF. The earliest in FDA's data is N17600, decided Aug 26, 1976.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Integra LifeSciences Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.